Readycure
Seoul
About Readycure
Readycure is developing an innovative solution focused on non-drug treatments by combining digital X-ray technology with artificial intelligence. This groundbreaking approach aims to provide effective healthcare solutions without relying on traditional medications. By leveraging AI to analyze digital X-ray images, Ready Cure’s solution offers advanced diagnostic capabilities and personalized treatment options. This innovative technology has the potential to improve patient outcomes, reduce reliance on pharmaceuticals, and transform healthcare practices, particularly in areas that can benefit from non-invasive treatments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $35.9K
- Funding stage: Seed
- Last round: Seed (May 2024)
- Website: ready-cure.com
- Phone: +82 2-959-2021
Industries & Categories
Artificial Intelligence (AI), Medical Device, Wellness
Canonical: https://fsome.com/organization/readycure-2808976 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.